Pharmaceutical Technology - February 2024

Pharmaceutical Technology - February 2024

Issue link: https://www.e-digitaleditions.com/i/1516147

Contents of this Issue

Navigation

Page 26 of 33

26 Pharmaceutical Technology ® Bio/Pharma Outsourcing Innovation eBook February 2024 PharmTech.com J Bettencourt/peopleimages.com - stock.adobe.com W orking with a contract development and manufacturing organization (CDMO) is a great way for smaller or diversified biotech companies, and even Big Pharma, to expand operations or modalities to reach the patients more efficiently. Outsourcing process development and manufacturing requires a lesser upfront investment with faster timelines while allowing teams at advanced therapy develop- ers to focus on innovation. However, this relation- ship can deeply impact the quality and efficacy of a product. This article explores the balancing act of ensuring regulatory compliance via internal proce- dures at a CDMO and what to consider when starting this relationship. Quality in the contract CDMOs will always have multiple customers, as this is how t heir business model is bui lt. It can be an uncomfortable position to seek a CDMO, particularly for those coming from Big Pharma, where there is direct quality oversight over processes. Looking for a CDMO with a wide platform of tools that can be tailored to meet regulatory compliance and both pro- vider and customer pharmaceutical quality system (PQS) requirements is important. Un for t unately, many CDMOs of fer qua lit y pro- cesses with minimal f lexibilit y for customers be- cause t his is t he easiest for t he CDMO to control. Doi ng t h is m i n i m i zes t he r isk s a ssociated w it h customer specific variations to processes, reduces costs for the CDMO, and is easier to defend during inspections. However, this can lead to a disconnect between the customer and the supplier. When CDMOs develop quality agreements with a greater focus on client needs, it can increase trust, compliance, and even make audits easier to manage. Complex procedures can be simplified by engaging Ensuring Quality in Contracted Support Iain McGhee is vice president of Quality at Ascend. This article looks at the relationship between a CDMO quality organization and the client.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - February 2024 - Pharmaceutical Technology - February 2024